Mark Warner Lectures on Competition, Trade & Investment Issues Affecting the Pharmaceutical Industry

Mark Warner lectured on Competition, Trade & Investment Issues Affecting the Pharmaceutical Industry at the Rutgers Institute for Information Policy and Law. (April 9, 2015) Mr. Warner discussed: the Canadian Competition Bureau approach to patent litigation “pay for delay” settlement agreements; Eli Lilly’s $500 million North American Trade Agreement (NAFTA) Chapter 11 investor-state arbitration claiming that Canadian patent laws unfairly discriminate against pharmaceutical companies; and pharmaceutical issues in the Canada-European Union Trade Agreement (CETA) and Trans-Pacific Partnership Agreement (TPP) negotiations. Mr. Warner was Legal Director of the Ontario Ministry of Economic Development & Trade and advised Ontario in the CETA negotiations and on several NAFTA Chapter 11 Investor-State Arbitrations. Mr. Warner, a Canadian and U.S. lawyer, has advised governments on trade policy and trade negotiations and previously worked on trade and competition issues as counsel in the OECD Trade Directorate.